Endonovo Therapeutics, Inc. (ENDV)
0.0001
0.00 (0.00%)
USD |
OTCM |
Aug 24, 16:00
Endonovo Therapeutics Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -9.53K% |
| March 31, 2024 | -1.88K% |
| December 31, 2023 | -2.65K% |
| September 30, 2023 | -10.73K% |
| June 30, 2023 | -257.7% |
| March 31, 2023 | -89.37% |
| December 31, 2022 | -37.12% |
| September 30, 2022 | -1.41K% |
| June 30, 2022 | -26.92K% |
| March 31, 2022 | -6.97K% |
| December 31, 2021 | -56.77K% |
| September 30, 2021 | -2.01K% |
| June 30, 2021 | -435.3% |
| March 31, 2021 | -377.8% |
| December 31, 2020 | -1.72K% |
| September 30, 2020 | -308.5% |
| June 30, 2020 | -289.9% |
| March 31, 2020 | -143.3% |
| December 31, 2019 | -40.77% |
| September 30, 2019 | -215.9% |
| June 30, 2019 | -206.4% |
| March 31, 2019 | -278.2% |
| December 31, 2018 | -305.7% |
| September 30, 2018 | -684.0% |
| June 30, 2018 | -1.17K% |
| Date | Value |
|---|---|
| March 31, 2018 | -2.21K% |
| December 31, 2017 | |
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | -163.2% |
| March 31, 2015 | -62.96% |
| December 31, 2014 | |
| September 30, 2014 | 23.30% |
| June 30, 2014 | 30.49% |
| March 31, 2014 | 52.25% |
| December 31, 2013 | 38.86% |
| September 30, 2013 | |
| June 30, 2013 | |
| March 31, 2013 | |
| December 31, 2012 | 0.00% |
| September 30, 2012 | 0.00% |
| June 30, 2012 | 0.00% |
| March 31, 2012 | 0.00% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Anika Therapeutics, Inc. | 65.15% |
| Accuray, Inc. | 34.76% |
| Perspective Therapeutics, Inc. | -1.31K% |
| Orthofix Medical, Inc. | 69.55% |
| ResMed, Inc. | 58.12% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Assets | -9.21K% |